| Property | Value |
|---|
|
?:abstract
|
-
Blood transfusions are vital components of modern medical treatment to which there is no viable alternative despite efforts to create artificial blood. Each year thousands of lives are saved by blood transfusions in every country of the world. However, blood and blood products can result in significant adverse events including immunologic reactions, infections, inefficacy, and others which can sometimes result in death and severe disability. Thus, the sustainability of safe blood systems and costs are considered to be at crisis level. In industrialized countries, the risk of transfusion-transmitted infections such as HIV, syphilis, hepatitis viruses B and C are very low [generally [<1 in a million units], but in developing countries [especially in Africa] blood safety is still not assured. Compounding the problem of blood/product safety with respect to infectious agents are new emerging infectious microbes that are not being routinely tested for in blood that are donated. This chapter reviews the infectious risk of blood transfusions, types, mode and geographic variation, and the methods being used by blood services to attenuate and prevent these risks.
|
|
?:creator
|
|
|
?:doi
|
-
10.1007/978-3-030-36966-8_8
|
|
?:doi
|
|
|
?:externalLink
|
|
|
?:journal
|
-
Current_Trends_and_Concerns_in_Infectious_Diseases
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/214ad13bba77e7d3c0ee7ec370c22cbe533d73a3.json
|
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7120358.xml.json
|
|
?:pmcid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}